First, although we clearly demonstrated that IGF-1 attenuated cardiac fibrosis in an AngII-infusion mouse model, cardiac fibrosis is already present in pathological conditions, such as hypertension or myocardial infarction, when antifibrotic treatment is started in humans. The gene discussed is IGF1; the disease is hypertensive disorder.